Understanding estrogen: what it actually does, beyond reproduction

When women hear "estrogen," most of us were taught it is the female hormone that runs the reproductive system. Period. Ovaries. Fertility. The end.

That definition is dramatically incomplete. Estrogen receptors are present in the brain, the bones, the heart, the blood vessels, the gut, the skin, the immune system, and almost every tissue in the body. Estrogen is one of the most powerful systemic signalling molecules a human can produce, and what it does extends far past the uterus.

Understanding what estrogen actually does, where it works, and how its rise and fall across your cycle affects everything from cognition to bone density to mood, is foundational to understanding your body. This article is the standalone deep-dive on estrogen pulled out from the cycle-phase guides, with the breadth it deserves.

The basics: what estrogen is

Estrogen is a class of three hormones in women: estradiol (E2), estrone (E1), and estriol (E3). Estradiol is the most potent and the dominant form in women of reproductive age. Estrone is the dominant form after menopause. Estriol is most prominent during pregnancy.

In a menstruating woman, estradiol is produced primarily by the developing follicle in the ovary during the first half of the cycle, with a smaller contribution from the corpus luteum after ovulation. Adipose tissue and the adrenal glands also produce small amounts year-round.

Estrogen works by binding to two distinct nuclear receptors: estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ). Both receptors bind estradiol with similar affinity, but they are distributed differently across tissues and have different downstream effects ^[1]. The mix of ERα and ERβ in a given tissue determines what estrogen does there.

• ERα predominates in the uterus, mammary glands, pituitary gland, skeletal muscle, adipose tissue, and bone
• ERβ predominates in the ovaries, prostate (in males), lungs, gastrointestinal tract, bladder, and parts of the brain
• Both are present in cardiovascular tissue, skin, and many regions of the central nervous system

This distinction matters because it explains why estrogen does so many different things in different tissues, and why selective estrogen receptor modulators (SERMs) used in medicine can target one tissue while sparing another.

The cycle: how estrogen rises and falls

In a typical 28-day cycle, estradiol follows a characteristic pattern ^[2][3]:

• Days 1 to 5 (menstrual phase): estradiol is at its lowest, around 25 to 75 pg/mL. The endometrial lining is shedding, and the new follicular cohort has not yet begun producing meaningful estradiol
• Days 6 to 13 (follicular phase): estradiol rises progressively as the dominant follicle develops. By day 10 to 12, levels are climbing rapidly
• Days 13 to 14 (late follicular / ovulation): estradiol peaks at around 200 to 400 pg/mL. This peak triggers the LH surge that causes ovulation
• Days 15 to 22 (luteal phase): estradiol drops sharply after ovulation, then rises again to a smaller secondary peak as the corpus luteum produces both estrogen and progesterone
• Days 23 to 28 (late luteal phase): estradiol declines steeply alongside progesterone, eventually triggering menstruation when both drop below a threshold

The shape matters. It is not a flat baseline but a dynamic, two-peak curve. Almost every system in your body adjusts to that curve, which is why phases of the cycle feel so different.

What estrogen actually does (by tissue)

This is where the standard education is most incomplete.

Brain

Estrogen has profound effects on the central nervous system. It modulates serotonin (promoting its synthesis, inhibiting its reuptake, and increasing receptor expression), dopamine, acetylcholine, and GABA signalling ^[4][5]. This is part of why estrogen behaves like a mild antidepressant in many women, and why the steepest estrogen drops (premenstrual, postpartum, perimenopause) are associated with the highest risks of mood disturbance.

Estrogen also supports synaptic plasticity, cerebral blood flow, glucose transport in neurons, and mitochondrial function in the brain ^[6]. The peri-ovulatory peak in estradiol is the cognitive high point of the cycle for many women: verbal memory, attention, mental flexibility, and language fluency all reach their best performance in the late follicular phase.

When estrogen declines (whether premenstrually, postpartum, or in perimenopause), women often report a real and measurable shift: word-finding difficulties, brain fog, slower processing speed, mood vulnerability. This is not imagination. The neurochemistry has changed.

Bone

Bone is in constant turnover throughout life: osteoclasts break it down, osteoblasts build it back. Estrogen restrains the osteoclasts. When estrogen falls, bone resorption outpaces formation ^[7].

This is why postmenopausal osteoporosis is overwhelmingly a women's disease. The estrogen drop at menopause accelerates bone loss; the cumulative deficit over 5 to 10 years is the difference between healthy bone density and clinical osteopenia or osteoporosis.

The implication for younger women: the peak bone mass you build in your late teens and twenties (which depends on adequate estrogen, calcium, vitamin D, vitamin K2, and weight-bearing exercise) is the bank you will draw on for the rest of your life. Conditions that suppress estrogen during this window (functional hypothalamic amenorrhea, anorexia nervosa, certain long-term hormonal contraceptive use) can compromise this peak permanently.

Cardiovascular system

Estrogen has multiple cardioprotective effects: it improves the lipid profile (raising HDL, lowering LDL), promotes vasodilation through nitric oxide signalling, has anti-inflammatory effects on the vascular endothelium, and influences clotting balance ^[1].

Women's risk of cardiovascular disease is dramatically lower than men's until menopause, after which the risk converges within 10 to 15 years. Estrogen's cardiovascular protection is the dominant driver of this sex difference. This does not mean every woman should take hormone replacement therapy at menopause (the decision is complex and individual), but it does mean the loss of estrogen at menopause is not just a "hot flashes" issue. It is a systemic cardiovascular shift.

Metabolism

Estrogen affects body composition, insulin sensitivity, fat distribution, and energy regulation. Women generally have lower insulin resistance and store fat differently (more subcutaneous, less visceral) during reproductive years compared to men. Estrogen drives this difference ^[6].

Across the cycle, you can sometimes notice the metabolic shift. Many women report better insulin sensitivity in the late follicular and early luteal phases (when estrogen is high) and slightly worse in the late luteal phase (when estrogen is dropping). The effect is usually subtle but real.

Skin, hair, and connective tissue

Estrogen supports collagen synthesis, skin hydration, hair follicle function, and connective tissue elasticity. The drop in estrogen at menopause is a major reason for the well-documented changes in skin (thinning, dryness, reduced elasticity) and hair (shedding, thinning) that many women experience.

Cyclical variation matters too. Many women notice their skin and hair look best in the late follicular phase, when estrogen is high. Premenstrual skin (broken out, dull, more reactive) reflects partly the estrogen drop.

Joints and ligaments

Estrogen affects ligament laxity, particularly in combination with relaxin. The peri-ovulatory estrogen peak is associated with increased ligament laxity and elevated ACL injury risk in female athletes (see our training article for the full picture).

Immune system and inflammation

Estrogen has complex, generally anti-inflammatory effects on the immune system ^[8]. This may partly explain why women's risk of autoimmune disease often rises after the steep estrogen drops of menopause or postpartum. It also explains why some autoimmune conditions improve during pregnancy (high estrogen) and flare postpartum (sudden withdrawal).

The withdrawal story: why estrogen falling is harder than estrogen being low

This is one of the most important and least-explained ideas in women's health.

Symptoms attributed to "low estrogen" are often more accurately described as estrogen withdrawal symptoms. The body adapts to a given level of estrogen over time. The problem is the change, not the absolute level.

The clearest example: hot flashes. The thinking has long been that hot flashes are caused by low estrogen, but the actual evidence is that absolute estradiol levels do not reliably differ between postmenopausal women with and without hot flashes ^[9]. The trigger is estrogen withdrawal, particularly in the perimenopausal transition when levels fluctuate wildly. The hypothalamus's thermoneutral zone narrows in response to falling estrogen, and small temperature changes trigger the disproportionate sweating-and-flushing response ^[10].

The same withdrawal mechanism is at play in:

• Premenstrual mood and physical symptoms: the steep late-luteal estradiol drop triggers PMS in susceptible women
• Postpartum mood: the 100 to 1000-fold pregnancy-to-postpartum estrogen drop is one of the most extreme withdrawal events the body experiences, and is mechanistically linked to postpartum depression
• Perimenopausal mood disturbance: chaotic fluctuation, not steady decline, is the driver of the worst symptoms

The implication: women's cycle-related mood and physical symptoms are often best understood as withdrawal responses, not deficiency states. This changes the interventions that make sense. Steady estrogen (whether through cyclical regularity, hormonal contraception's flat dose, or stable HRT) prevents withdrawal symptoms more effectively than trying to "boost" estrogen during low points.

What this means for nutrition

The nōuxx cycle routine does not directly supplement estrogen. The body produces its own; that production cannot be replaced with food or supplements, and the regulatory system is too tightly controlled to be useful to intervene with most "estrogen-supporting" supplements.

What nutrition can do is support the systems that interact with estrogen:

• Bone health: calcium, vitamin D, vitamin K2, magnesium (all in the routine) support the bone matrix that estrogen helps protect
• Liver clearance of estrogen: B vitamins (folate, B6, B12), choline, and inulin (a prebiotic) support the gut-liver axis that processes and clears estrogen metabolites. Healthy clearance matters as much as healthy production
• Cyclical mood support: B6, magnesium, L-tryptophan, and choline support the neurotransmitter systems estrogen modulates
• Antioxidant support: vitamin E, vitamin C, selenium, CoQ10, and beta-carotene support the oxidative stress balance that affects estrogen-receptor signalling

This is not a list of "estrogen boosters." It is a list of nutrients that support the systems estrogen works on, which is what evidence-based supplementation can plausibly do.

For the specific clinical situations of menopause or estrogen-related health conditions, the conversation moves from supplementation to medical care: HRT, SERMs, and other prescription interventions are evidence-based options that require a doctor.

Common questions

Can I "balance" my estrogen with diet?

The phrase "balance your hormones" is mostly marketing. Estrogen is tightly regulated by the hypothalamic-pituitary-ovarian axis, and you cannot meaningfully increase or decrease your own estradiol production through diet. What diet can do is support the liver and gut systems that clear estrogen metabolites, support the tissues estrogen acts on, and provide stable energy and nutrient intake that supports a regular cycle.

What about phytoestrogens (soy, flax)?

Phytoestrogens are plant compounds that bind weakly to estrogen receptors. Their net effect in women depends on context: with low endogenous estrogen, they may produce a mild estrogenic effect; with normal endogenous estrogen, they can act as mild antagonists. The clinical effect in most women is modest. Long-term moderate intake of soy and flax does not appear to cause hormone-disrupting effects in healthy women and may have modest cardiovascular and bone benefits.

Does the pill provide estrogen?

Combined oral contraceptives provide synthetic ethinyl estradiol, which suppresses your natural cycle (see our pill article). The synthetic estrogen substitutes for endogenous estradiol at a flat dose. It is contraception, not hormone replacement therapy in the classical sense.

Can I test my estrogen levels?

Estradiol can be tested via blood at any specific point, but the level varies dramatically across the cycle and across women, so a single result is hard to interpret without context. A more useful test is the trend across a full cycle (impractical clinically) or in specific contexts: suspected perimenopause (where FSH and estradiol together are informative), suspected hypothalamic amenorrhea (where estradiol is typically low and FSH/LH normal), or fertility evaluation. A blood estradiol test in a typical woman with a regular cycle, on a typical day, does not tell you much.

What about xenoestrogens and endocrine disruptors?

Synthetic chemicals (BPA, certain phthalates, some pesticides, parabens) can weakly interact with estrogen receptors. The clinical significance for healthy adult women is debated. The current EU regulatory position is precautionary (limits on certain chemicals in food contact materials, for example). Reasonable steps include minimising heat-exposed plastic for food, choosing fragrance-free personal care products when possible. The evidence does not support panic, and most "detoxing" claims overstate the evidence on what diet can do.

Does breastfeeding affect estrogen?

Yes. Prolactin (the milk-production hormone) suppresses ovulation and keeps estrogen low during exclusive breastfeeding. This is part of why menstruation is often absent for months postpartum, and why vaginal dryness and reduced libido are common during breastfeeding. The low-estrogen state is temporary and resolves when breastfeeding patterns change.

What changes about estrogen in perimenopause?

Perimenopause (typically late 30s to mid-40s) is characterised not by steady decline but by chaotic fluctuation: cycles where estradiol surges higher than usual alternating with cycles where it crashes lower. This is harder for the body to adapt to than the eventual stable low-estrogen state of postmenopause. Symptoms (hot flashes, mood disturbance, irregular cycles, sleep disruption) reflect this volatility. The transition typically lasts 4 to 10 years.

Should I be worried about high estrogen?

"Estrogen dominance" is a popular wellness term not well-supported by clinical endocrinology in healthy women. True estrogen excess is rare and usually associated with specific conditions (estrogen-producing tumours, certain PCOS subtypes, severe insulin resistance, exposure to exogenous estrogens). Most women with "estrogen dominance"-style symptoms (heavy periods, breast tenderness, mood swings) are more accurately described as having normal estrogen and low or insufficient progesterone, particularly in perimenopause. The diagnostic and therapeutic implications are different.

The bottom line

Estrogen is one of the most consequential hormones in the female body, and its scope reaches far beyond the reproductive system. Brain, bone, heart, metabolism, skin, immune system, joints: all carry estrogen receptors, all respond to the cyclical rise and fall, all are affected when estrogen withdraws sharply (premenstrually, postpartum, perimenopausally).

Knowing this changes how you read your own body. The cognitive sharpness you feel mid-cycle, the bone health you build in your twenties, the mood vulnerability before your period, the skin changes around menopause, are not separate stories. They are all estrogen.

The cycle is not just about fertility. It is the rhythm that runs through almost every system you have. Working with that rhythm, rather than ignoring it or treating cycle symptoms as character flaws, is what cycle-aware living means in practice.

References

[1] Hodges YK, et al. Estrogen Receptors α and β. Circulation 2000;101(15):1792-1798. doi.org/10.1161/01.cir.101.15.1792

[2] Reed BG, Carr BR. Proliferative and Follicular Phases of the Menstrual Cycle. Statpearls. Treasure Island (FL): Statpearls Publishing 2024. ncbi.nlm.nih.gov/books/NBK542229

[3] Thiyagarajan DK, Basit H, Jeanmonod R. Physiology, Menstrual Cycle. Statpearls. Treasure Island (FL): Statpearls Publishing 2024. ncbi.nlm.nih.gov/books/NBK500020

[4] McEwen B. Estrogen Actions Throughout the Brain. Recent Progress in Hormone Research 2002;57:357-384. doi.org/10.1210/rp.57.1.357

[5] Sherwin BB. Estrogen and Cognitive Functioning in Women. Endocrine Reviews 2003;24(2):133-151. doi.org/10.1210/er.2001-0016

[6] Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Frontiers in Neuroendocrinology 2014;35(1):8-30. doi.org/10.1016/j.yfrne.2013.08.001

[7] Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”. Endocrine Reviews 2021;42(6):872-872. doi.org/10.1210/endrev/bnab024

[8] Lu J, et al. The estrogen–brain interface in neuroinflammation: a multidimensional mechanistic insight. Frontiers in Aging Neuroscience 2025;17. doi.org/10.3389/fnagi.2025.1671552

[9] Bansal R, Aggarwal N. Hot Flashes. Statpearls. Treasure Island (FL): Statpearls Publishing 2024. ncbi.nlm.nih.gov/books/NBK539827

[10] Zhang Z, et al. The Effects of Estrogens on Neural Circuits That Control Temperature. Endocrinology 2021;162(8). doi.org/10.1210/endocr/bqab087

[11] Biason-Lauber A, Lang-Muritano M. Estrogens: Two nuclear receptors, multiple possibilities. Molecular and Cellular Endocrinology 2022;554:111710. doi.org/10.1016/j.mce.2022.111710

[12] Yaşar P, et al. Molecular mechanism of estrogen-estrogen receptor signaling. Reproductive Medicine and Biology 2017;16(1):4-20. doi.org/10.1002/rmb2.12006

[13] Delamater L, Santoro N. Management of the Perimenopause. Clinical Obstetrics and Gynecology 2018;61(3):419-432. doi.org/10.1097/GRF.0000000000000389

[14] Reed BG, Carr BR. The Normal Menstrual Cycle and the Control of Ovulation. Endotext. Mdtext.com 2018. notion.so/36ccc438fea481c7bf5ef0cbf23a80e4

[15] Beyond Hot Flashes: The Role of Estrogen Receptors in Menopausal Mental Health and Cognitive Decline. Brain Sciences (MDPI) 2025. mdpi.com/2076-3425/15/9/1003

[16] Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Seminars in Reproductive Medicine 2005;23(2):117-25. doi.org/10.1055/s-2005-869479